Literature DB >> 19884157

Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.

Paola Piccolo1, Ilaria Lenci, Claudia Telesca, Daniele Di Paolo, Franco Bandiera, Luigi De Melia, Orazio Sorbello, Giuseppina Renier, Giovanni L Ricci, Lorenzo Nosotti, Mario Romano, Adriano De Santis, Massimo Levrero, Giorgio Antonucci, Maria Antonella Longo, Brigida E Annicchiarico, Mario Angelico.   

Abstract

We investigated the patterns of chronic hepatitis B virus (HBV)-related disease in a large cohort of HBsAg-positive patients, in Central Italy, by collecting a screening form with demographic, clinical and laboratory data. Overall, 737 HBsAg-positive cases were included (70% male; median age 52 years): 30% were inactive HBsAg carriers, 51% had chronic hepatitis B (CHB) and 19% had HBV-related cirrhosis. Patients from non-European Union (EU) countries (n = 65) were significantly younger, had a higher prevalence of HBeAg-positive infection and hepatitis delta virus (HDV) co-infection than patients of Italian origin. Therefore, as immigration from non-EU countries continues to grow, we can expect a change in the landscape of HBV-related disease in our area.

Entities:  

Mesh:

Year:  2009        PMID: 19884157     DOI: 10.1093/eurpub/ckp168

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  3 in total

1.  Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.

Authors:  Fabio Tramuto; Walter Mazzucco; Carmelo Massimo Maida; Andrea Affronti; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Community Health       Date:  2012-06

Review 2.  Recent advances in managing hepatitis D.

Authors:  Cihan Yurdaydin
Journal:  F1000Res       Date:  2017-08-30

3.  Low eligibility for hepatitis B treatment in the Brazilian public health system.

Authors:  Cristiane Faria Oliveira Scarponi; Marco Antônio Ferreira Pedrosa; Marcos Paulo Gomes Mol; Michael John Mascarenhas Hardman; Dirceu Bartolomeu Greco
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-08       Impact factor: 2.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.